David J. Arthur

Insider Reports History

Location
Houston, TX
Signature
/s/Mark Rosenblum, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David J. Arthur:

Company Role Class Num Shares Value Price $ Report Date Ownership
Salarius Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (right to buy) 20,500 11 Apr 2024 Direct

Insider Reports Filed by David J. Arthur

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLRX Salarius Pharmaceuticals, Inc. 11 Apr 2024 1 $0 4 Chief Executive Officer, Director 12 Apr 2024, 16:50
SLRX Salarius Pharmaceuticals, Inc. 13 Feb 2023 1 $0 4 Chief Executive Officer, Director 15 Feb 2023, 15:04
SLRX Salarius Pharmaceuticals, Inc. 03 Jan 2023 1 $0 4 Chief Executive Officer, Director 05 Jan 2023, 16:33
SLRX Salarius Pharmaceuticals, Inc. 03 Nov 2022 1 +$4,670 4/A Chief Executive Officer, Director 12 Dec 2022, 17:34
SLRX Salarius Pharmaceuticals, Inc. 03 Nov 2022 1 +$17,340 4/A Chief Executive Officer, Director 08 Nov 2022, 16:42
SLRX Salarius Pharmaceuticals, Inc. 26 May 2022 5 +$7,985 4 Chief Executive Officer, Director 31 May 2022, 17:17
SLRX Salarius Pharmaceuticals, Inc. 03 May 2022 1 +$1,863 4 Chief Executive Officer, Director 05 May 2022, 16:06
SLRX Salarius Pharmaceuticals, Inc. 03 Mar 2022 1 +$54,540 4 Chief Executive Officer, Director 09 Mar 2022, 15:01
SLRX Salarius Pharmaceuticals, Inc. 20 Jan 2022 1 $0 4 Chief Executive Officer, Director 21 Jan 2022, 15:08
SLRX Salarius Pharmaceuticals, Inc. 03 Nov 2021 1 +$5,700 4 Chief Executive Officer, Director 05 Nov 2021, 14:58
SLRX Salarius Pharmaceuticals, Inc. 17 Aug 2021 2 +$3,582 4 Chief Executive Officer, Director 17 Aug 2021, 16:08